Seizinger Bernd R.

Aprea Therapeutics, Inc. · Director

Seizinger Bernd R. is listed in filings as Director at Aprea Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2025, including purchase activity. Recent filings connect the profile to Aprea Therapeutics, Inc. (APRE). The current snapshot covers public activity from Jun 21, 2024 to Jun 9, 2025. Reported amounts are shown as $7.6K to $17.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceLast Price
Aprea Therapeutics, Inc.APRE$27k10k sharesBuyOct 11, 2024$2.68$0.8926